Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

New Drugs for Preventing Migraines

Aschenbrenner, Diane S., MS, RN

AJN The American Journal of Nursing: May 2019 - Volume 119 - Issue 5 - p 22
doi: 10.1097/01.NAJ.0000557909.12528.af
Drug Watch
Buy
  • The Food and Drug Administration has approved three drugs from a new drug class designed to prevent migraine headaches. The drugs target calcitonin gene–related peptide, a substance involved in the excessive cerebral vasodilation that leads to migraine headaches.
  • The three new products are administered subcutaneously once per month.

Diane S. Aschenbrenner is an assistant professor at Notre Dame of Maryland University in Baltimore. She also coordinates Drug Watch: daschenbrenner@ndm.edu.

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.